(Q41764136)

9 October 2017

Determination of salirasib (S-trans,trans-farnesylthiosalicylic acid) in human plasma using liquid chromatography-tandem mass spectrometry (English)

1 reference

liquid chromatography-tandem mass spectrometry

9 October 2017

1 reference

4

1 reference

9 October 2017

Ming Zhao

1

1 reference

9 October 2017

Ping He

2

1 reference

9 October 2017

Linping Xu

3

1 reference

9 October 2017

Dan Laheru

5

1 reference

9 October 2017

Michelle A Rudek

6

1 reference

9 October 2017

22 May 2008

1 reference

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

9 October 2017

1 reference

9 October 2017

869

1 reference

9 October 2017

1-2

1 reference

9 October 2017

142-145

1 reference

describes a project that uses

9 October 2017

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

cites work

Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086377

The Ras branch of small GTPases: Ras family members don't fall far from the tree

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086377

Targeting of K-Ras 4B by S-trans,trans-farnesyl thiosalicylic acid

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086377

Novel Ras antagonist blocks human melanoma growth

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086377

Stringent structural requirements for anti-Ras activity of S-prenyl analogues

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086377

Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086377

K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086377

Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086377

Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086377

Farnesyl thiosalicylic acid chemosensitizes human melanoma in vivo

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086377

The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3086377

Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18534927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JCHROMB.2008.05.028

1 reference

9 October 2017

1 reference

9 October 2017

PubMed publication ID

18534927

1 reference